Literature DB >> 16874867

A population-based follow-up study on gallstone disease among type 2 diabetics in Kinmen, Taiwan.

Tao-Hsin Tung1, Hsiao-Man Ho, Hui-Chuan Shih, Pesus Chou, Jorn-Hon Liu, Victor-T K Chen, De-Chuan Chan, Chi-Ming Liu.   

Abstract

AIM: To assess the incidence of and risk factors for gallstone disease (GSD) among type 2 diabetics in Kinmen, Taiwan.
METHODS: A screening program for GSD was performed by two specialists who employed real-time abdominal ultrasound to examine the abdominal region after patients had fasted for at least eight hours. Screening, which was conducted in 2001, involved 848 patients diagnosed with type 2 diabetes. After exclusion of 63 subjects with prevalent GSD, 377 participants without GSD were invited in 2002 for a second round of screening. A total of 281 (74.5%) subjects were re-examined.
RESULTS: Among the 281 type 2 diabetics who had no GSD at the first screening, 10 had developed GSD by 2002. The incidence was 3.56% per year (95% CI: 1.78% per year-6.24% per year). Using a Cox regression model, age (RR = 1.07, 95% CI: 1.00-1.14), waist circumference (RR = 1.12, 95% CI: 1.01-1.29), and ALT (RR = 1.13, 95%CI: 1.01-1.26) appeared to be significantly correlated with development of GSD.
CONCLUSION: Older age is a known risk factor for the development of GSD. Our study shows that greater waist circumference and elevated ALT levels are also associated with the development of GSD among type 2 diabetics in Kinmen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874867      PMCID: PMC4125642          DOI: 10.3748/wjg.v12.i28.4536

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

2.  Alanine aminotransferase levels: what's normal?

Authors:  Marshall M Kaplan
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

3.  A community-based epidemiologic study on gallstone disease among type 2 diabetics in Kinmen, Taiwan.

Authors:  Chi-Ming Liu; Tao-Hsin Tung; Jorn-Hon Liu; Wen-Ling Lee; Pesus Chou
Journal:  Dig Dis       Date:  2004       Impact factor: 2.404

4.  Impaired glucose tolerance, diabetes mellitus, and gallstone disease: an extended study of male self-defense officials in Japan.

Authors:  S Sasazuki; S Kono; I Todoroki; S Honjo; Y Sakurai; K Wakabayashi; M Nishiwaki; H Hamada; H Nishikawa; H Koga; S Ogawa; K Nakagawa
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

Review 5.  Risk factors for the development of cholelithiasis in man (second of two parts).

Authors:  L J Bennion; S M Grundy
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

Review 6.  Pathophysiology of cholesterol gallstone disease.

Authors:  N Méndez-Sánchez; R Cárdenas-Vázquez; G Ponciano-Rodríguez; M Uribe
Journal:  Arch Med Res       Date:  1996       Impact factor: 2.235

7.  Gallstones and diabetes: a case-control study in a free-living population sample.

Authors:  A De Santis; A F Attili; S Ginanni Corradini; E Scafato; A Cantagalli; C De Luca; G Pinto; D Lisi; L Capocaccia
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

8.  Age is one of the risk factors in developing gallstone disease in Taiwan.

Authors:  C Y Chen; C L Lu; Y S Huang; T N Tam; Y Chao; F Y Chang; S D Lee
Journal:  Age Ageing       Date:  1998-07       Impact factor: 10.668

9.  Bile lipid composition and bile acid pool size in diabetes.

Authors:  M P de Leon; R Ferenderes; N Carulli
Journal:  Am J Dig Dis       Date:  1978-08

10.  Prospective study of abdominal adiposity and gallstone disease in US men.

Authors:  Chung-Jyi Tsai; Michael F Leitzmann; Walter C Willett; Edward L Giovannucci
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

View more
  11 in total

1.  Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice.

Authors:  Xiaoyun Feng; Cuiling Zhu; Sojin Lee; Jingyang Gao; Ping Zhu; Jun Yamauchi; Chenglin Pan; Sucha Singh; Shen Qu; Rita Miller; Satdarshan P Monga; Yongde Peng; H Henry Dong
Journal:  J Biol Chem       Date:  2020-04-09       Impact factor: 5.157

2.  A population-based cohort study of symptomatic gallstone disease in diabetic patients.

Authors:  Chi-Ming Liu; Chung-Te Hsu; Chung-Yi Li; Chu-Chieh Chen; Meng-Lun Liu; Jorn-Hon Liu
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

3.  Metabolic syndrome and gallstone disease.

Authors:  Li-Ying Chen; Qiao-Hua Qiao; Shan-Chun Zhang; Yu-Hao Chen; Guan-Qun Chao; Li-Zheng Fang
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

4.  Evaluation of Factors Affecting the Type of Gallstone.

Authors:  Sonay Baltacı Goktas; Manuk Manukyan; Deniz Selimen
Journal:  Indian J Surg       Date:  2015-07-12       Impact factor: 0.656

Review 5.  Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review.

Authors:  Lujie Chen; Yu-Ting Peng; Fu-Li Chen; Tao-Hsin Tung
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

6.  A 10-year follow-up of a longitudinal study of gallstone prevalence at necropsy in South East England.

Authors:  Hamed N Khan; Margaret Harrison; Eryl E Bassett; Tom Bates
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

7.  Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study.

Authors:  Shih-Chang Hung; Kuan-Fu Liao; Shih-Wei Lai; Chia-Ing Li; Wen-Chi Chen
Journal:  BMC Gastroenterol       Date:  2011-10-17       Impact factor: 3.067

8.  Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study.

Authors:  Masood Sepehrimanesh; Ramin Niknam; Fardad Ejtehadi; Mohammad Reza Fattahi; Alireza Safarpour
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-01       Impact factor: 3.168

9.  Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan.

Authors:  Jau-Yuan Chen; Chung-Te Hsu; Jorn-Hon Liu; Tao-Hsin Tung
Journal:  BMC Gastroenterol       Date:  2014-04-28       Impact factor: 3.067

10.  Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study.

Authors:  Tamio Teramoto; Kazunori Abe; Takehiko Taneyama
Journal:  Cardiovasc Diabetol       Date:  2013-11-06       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.